Skip to main content
    P

    Phibro Animal Health Corporation (PAHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $35.02
    -0.95 (-2.64%)

    Market Cap: $1.46B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Phibro Animal Health Corporation (PAHC) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Phibro Animal Health reported revenue of $1.52B for the fiscal year ended Jun 30, 2026, up 17.1% from the year before. That year, net income was $99.72M with a net margin of 6.6%, operating cash flow was $68.95M and free cash flow was $9.87M. The quarter ended Sep 30, 2026 had revenue of $386.77M and net income of $29.52M.

    Revenue and Margins

    The operating margin was 12.8% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $764.28M, a compound annual rate of 7.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Jun 2026$1.52B+17.1%33.8%12.8%6.6%
    Jun 2025$1.30B+27.4%30.9%8.5%3.7%
    Jun 2024$1.02B+4.1%30.8%5.2%0.2%
    Jun 2023$977.89M+3.8%30.5%7.3%3.3%
    Jun 2022$942.26M+13.1%30.3%8.4%5.2%
    Jun 2021$833.35M+4.1%32.6%9.0%6.5%
    Jun 2020$800.35M-3.3%32.1%8.6%4.2%
    Jun 2019$828.00M+1.0%32.0%10.1%6.6%
    Jun 2018$819.98M+7.3%32.5%12.1%7.9%
    Jun 2017$764.28MN/A32.5%12.8%8.5%
    Annual, fiscal years ended Jun 2017 to Jun 2026

    Income Statement

    In the fiscal year ended Jun 2026, net income rose 106.6% from the year before. In the quarter ended Sep 2026, net income rose 11.3% from the same quarter a year earlier.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Revenue$1.52B$1.30B$1.02B$977.89M$942.26M$833.35M$800.35M$828.00M$819.98M$764.28M
    Cost of revenue$1.01B$896.27M$704.59M$679.65M$656.86M$561.97M$543.47M$563.37M$553.10M$516.04M
    Gross profit$512.51M$399.94M$313.09M$298.24M$285.40M$271.38M$256.88M$264.62M$266.88M$248.24M
    Operating income$194.40M$110.47M$53.31M$71.85M$78.99M$74.87M$69.19M$83.23M$98.93M$97.93M
    Net income$99.72M$48.26M$2.42M$32.61M$49.17M$54.38M$33.55M$54.71M$64.88M$64.61M
    EBITDA$235.61M$150.22M$66.67M$104.13M$117.50M$112.07M$101.59M$111.73M$127.81M$125.06M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$386.77M$396.75M$383.54M$373.91M$363.89M$378.70M$347.82M$309.26M$260.43M$273.16M$263.22M$249.94M
    Gross profit$128.54M$134.40M$125.67M$132.66M$119.78M$110.01M$104.57M$101.87M$83.50M$87.15M$79.60M$78.62M
    Operating income$49.64M$48.16M$44.65M$50.33M$51.26M$33.72M$33.52M$25.53M$17.70M$18.42M$19.92M$15.70M
    Net income$29.52M$21.71M$24.02M$27.46M$26.53M$17.22M$20.88M$3.19M$6.97M$752.00K$8.40M$1.27M
    Last 12 quarters

    Balance Sheet

    As of Jun 2026, total debt of $732.79M exceeded cash and equivalents by $671.38M.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Total assets$1.50B$1.36B$982.18M$971.40M$931.70M$841.33M$784.10M$726.67M$671.68M$623.40M
    Current assets$935.51M$810.61M$601.00M$585.72M$566.23M$498.91M$451.84M$466.16M$415.46M$363.67M
    Cash and equivalents$61.42M$68.04M$70.61M$41.28M$74.25M$50.21M$36.34M$57.57M$29.17M$56.08M
    Total liabilities$1.12B$1.08B$725.54M$688.89M$669.26M$602.80M$595.90M$510.66M$486.73M$472.24M
    Short-term debt$25.02M$16.25M$29.80M$22.30M$15.00M$9.38M$18.75M$12.54M$12.58M$6.25M
    Long-term debt$707.77M$702.43M$458.29M$452.54M$417.93M$382.71M$368.26M$313.63M$299.80M$306.89M
    Shareholder equity$385.48M$285.68M$256.64M$282.51M$262.44M$238.53M$188.20M$216.01M$184.95M$151.16M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.51B$1.50B$1.45B$1.41B$1.39B$1.36B$1.32B$1.29B$966.29M$982.18M$979.03M$972.71M
    Total liabilities$1.10B$1.12B$1.08B$1.07B$1.07B$1.08B$1.05B$1.04B$707.76M$725.54M$708.94M$701.90M
    Cash and equivalents$75.55M$61.42M$54.93M$55.49M$72.77M$68.04M$60.35M$67.07M$51.84M$70.61M$50.23M$32.97M
    Shareholder equity$417.67M$385.48M$361.83M$332.36M$311.68M$285.68M$265.99M$246.80M$258.53M$256.64M$270.09M$270.80M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Jun 2026, free cash flow was 14.3% of operating cash flow. Dividends came to 197.2% of it.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Operating cash flow$68.95M$80.12M$87.59M$13.31M$31.65M$48.31M$59.35M$47.17M$70.01M$98.39M
    Capital expenditures$59.09M$38.29M$41.24M$51.79M$37.04M$29.32M$34.05M$29.89M$18.55M$20.88M
    Free cash flow$9.87M$41.83M$46.36M-$38.48M-$5.39M$18.99M$25.30M$17.28M$51.46M$77.50M
    Dividends paid$19.46M$19.45M$19.44M$19.44M$19.44M$19.43M$19.42M$18.59M$16.07M$15.83M
    Investing cash flow-$71.45M-$288.69M-$48.19M-$74.02M-$22.58M-$18.58M-$120.39M-$14.13M-$84.61M-$21.94M
    Financing cash flow-$6.56M$207.13M-$6.77M$26.99M$16.34M-$17.00M$40.94M-$4.11M-$11.78M-$53.74M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$26.08M$24.09M$16.21M$19.35M$9.30M$21.27M$43.15M$3.08M$12.62M$28.43M$11.41M$31.56M
    Capital expenditures$18.78M$18.87M$15.32M$11.10M$13.81M$13.14M$7.75M$7.82M$9.58M$13.07M$9.73M$10.96M
    Free cash flow$7.30M$5.22M$890.00K$8.26M-$4.50M$8.13M$35.41M-$4.75M$3.04M$15.36M$1.68M$20.60M
    Last 12 quarters

    Frequently Asked Questions About PAHC

    What is Phibro Animal Health's annual revenue?

    Phibro Animal Health reported revenue of $1.52B for the fiscal year ended Jun 30, 2026.

    How fast is Phibro Animal Health's revenue growing?

    Revenue was up 17.1% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 15.8%.

    Is Phibro Animal Health profitable?

    Yes. Phibro Animal Health reported net income of $99.72M for the fiscal year ended Jun 30, 2026, with a net margin of 6.6%.

    How much free cash flow does PAHC generate?

    For the fiscal year ended Jun 30, 2026, operating cash flow of $68.95M minus capital expenditures of $59.09M produced free cash flow of $9.87M.

    How much debt does Phibro Animal Health have?

    The balance sheet dated Jun 30, 2026 reported long-term debt of $707.77M, short-term debt of $25.02M and cash and equivalents of $61.42M.